YZR

Co-founders Prof. Dr. Reinhard Meier and Markus Feuerecker lead investment decisions. Meier is a former practicing physician who transitioned into tech investing. Feuerecker is a career healthcare investor with experience across venture, growth, and buyout private equity. The legal or governance documents naming specific committee members are not public.

YZR's sourcing draws on its founders' combined clinical and investment networks across Europe. Meier's medical background provides access to research hospitals and digital health spinouts, while Feuerecker's buyout and growth-stage relationships surface later-stage visibility. The firm also cites its operator experience as a differentiator, claiming that its team of physicians, scientists, and exited founders generates referrals from within the European health-tech ecosystem.

YZR invests directly in operating companies and leads or co-leads funding rounds. There is no public evidence that the firm makes fund-of-fund commitments or allocates capital to other external VC managers.